FindTrial
Sign In

ROLE OF INDIVIDUALIZED HOMOEOPATHIC MANAGEMENT IN CASES OF GOUT

TO STUDY THE ROLE OF INDIVIDUALIZED HOMOEOPATHIC MANAGEMENT IN CASES OF GOUT A PROSPECTIVE INTERVENTIONAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085242
Enrollment
55
Registered
2025-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINES: INDIVIDUALIZED HOMOEOPATHIC MEDICINES WILL BE USED IN SELECTIVE POTENCY, AS IN REQUIRED REPETITION FOR 15 DAYS Control Intervention1: NOT APPLICAB

Sponsors

YASH PATIDAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient between the ages of 18 to 78. 2.Patients suffering from chronic gout with high UA levels (27 mg/dL) 3.The gout had to be clinically apparent, with symptoms such as joint pains 4.The patients giving their consent to participate in study.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Patient with septic arthritis, trauma, renal failure. 3.Patients already undergoing treatment with other system of medicine. 4.Cases with less than 6 follow up.

Design outcomes

Primary

MeasureTime frame
1.To evaluate the role of individualized homoeopathic medicine in Gout 2.To investigate the role of individualized homoeopathic medicine in reducing serum uric acid levels in gout patients. 3.To improve the quality of life of the patients.Timepoint: 3 MONTHS—

Secondary

MeasureTime frame
GOUT ASSESSMENT QUESTIONNARE 2.O IS USED FOR ASSESSMENT FOR GOUT. HIGHER SCORE = WORSE CONDITION / GREATER GOUT IMPACTTimepoint: 3 MONTHS—

Countries

India

Contacts

Public ContactDR MAYANK ROY

JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE

Dr.mayankroy@gmail.com7405002111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026